MEDICAL DIAGNOSTIC ASSAY KITS COMPRISED

Brand Owner (click to sort) Address Description
IMMUNOSEQ DX ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 Eastlake Avenue E, Suite 200 Seattle WA 98102 Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune disease and infection;IMMUNOSE EQ DX;Providing medical diagnostic and prognostic testing for cancer, autoimmune disease and infection, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; medical services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories;DX;Medical laboratory services;
NOVORIG Rapid Novor Inc. 137 Glasgow St., Unit 450 Kitchener, Ontario N2G4X8 Canada Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune diseases and infections;Proteomics analysis test kits comprising reagents for detecting, quantifying and characterizing antibody proteins in a biological sample for scientific research purposes;Providing medical diagnostic and prognostic testing for cancer, autoimmune diseases and infections, and the medical analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. An assay pad for measuring the concentration of HDL-associated cholesterol in a sample, a method for using the pad, and a diagnostic assay device for carrying out the method are described. The assay pad includes a polymer adhesive or heat laminate bond. The assay design prevents interference by reagents used for such removal with the HDL quantification reaction or with other assays carried out on the same sample. If desired, removal of non-HDL lipoproteins and assay of HDL cholesterol can be carried out without interruption of the assay.